The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

AHRMM What's New
Begin the year with a fresh organizational outlook using AHRMM’s Policies and Procedures Manual for the Health Care Supply Chain, 2nd Edition.…
AHRMM What's New
The fundamentals of health care supply chain management are the glue that holds the entire health care organization together. Whether you are new or…
Webcast
Crises can stress even the strongest leaders.
On-Demand Educational Webinars
Consider how the four emerging themes on purchased services and their leading practices can deliver improved margins.
AHRMM20+ Cost, Quality and Outcomes (CQO) Summit white paper describes lessons learned by health care supply chain during the COVID-19 pandemic, best…
On-Demand Educational Webinars
Achieve cost savings through methods to increase clinical buy-in and adherence to supply chain decision. while maintaining a focus on clinical…